Skip to content

TCG Crossover Management, LLC

Follow

13F filer, CIK 1839948, PALO ALTO, CA

TCG Crossover Management, LLC reported $3,539,842,492 across 57 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-16. Its ten largest share positions make up 53.33% of the portfolio.

Accepted , ingested 13F-HR 0001214659-26-014306

Period
2026-09-30
Reported value
$3.54B
Holdings
57
Top 10 weight
53.33%
New
8
Sold out
5

Largest buys vs the previous quarter

SecurityShares changeApprox. value
KRSAnew+4,549,587$146M
ADRXnew+4,116,452$82.1M
ENTXnew+12,254,901$35.7M
TARSnew+388,164$30.5M
OBXnew+2,196,138$30.2M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
ABVXreduced-2,344,796-$232M
COGTreduced-2,354,433-$75.4M
RVMDexited-340,899-$63.8M
TNGXreduced-2,308,158-$57.6M
SRZNexited-1,473,101-$38.2M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2026

Share positions as resolved from 13F-HR 0001214659-26-014306, largest first. % of portfolio is the value over $3,539,842,492, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
ABVXABIVAX SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 6,056,596 shares; 2025Q1: 6,056,596 shares; 2025Q2: 6,056,596 shares; 2025Q3: 7,111,596 shares; 2025Q4: 7,111,596 shares; 2026Q1: 6,481,085 shares; 2026Q2: 6,007,834 shares; 2026Q3: 3,663,038 shares 3,663,038$363M10.25%-2,344,796Timeline
CGONCG ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,670,206 shares; 2025Q1: 3,670,206 shares; 2025Q2: 3,670,206 shares; 2025Q3: 3,670,206 shares; 2025Q4: 3,670,206 shares; 2026Q1: 3,670,206 shares; 2026Q2: 3,670,206 shares; 2026Q3: 3,670,206 shares 3,670,206$260M7.35%0Timeline
AMLXAMYLYX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 4,643,812 shares; 2025Q1: 5,943,812 shares; 2025Q2: 5,943,812 shares; 2025Q3: 6,243,812 shares; 2025Q4: 6,243,812 shares; 2026Q1: 6,243,812 shares; 2026Q2: 6,243,812 shares; 2026Q3: 6,243,812 shares 6,243,812$182M5.13%0Timeline
SYRESPYRE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 1,100,582 shares; 2025Q4: 1,900,582 shares; 2026Q1: 1,900,582 shares; 2026Q2: 1,900,582 shares; 2026Q3: 1,900,582 shares 1,900,582$169M4.78%0Timeline
TNGXTANGO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 10,736,000 shares; 2025Q1: 10,736,000 shares; 2025Q2: 10,736,000 shares; 2025Q3: 8,536,196 shares; 2025Q4: 12,762,094 shares; 2026Q1: 10,531,071 shares; 2026Q2: 9,081,201 shares; 2026Q3: 6,773,043 shares 6,773,043$169M4.77%-2,308,158Timeline
ZLABZAI LAB LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 6,137,627 shares; 2026Q3: 6,229,081 shares 6,229,081$164M4.64%+91,454Timeline
IMVTIMMUNOVANT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,660,933 shares; 2026Q1: 4,457,988 shares; 2026Q2: 4,457,988 shares; 2026Q3: 4,457,988 shares 4,457,988$151M4.25%0Timeline
DNTHDIANTHUS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,501,624 shares; 2025Q1: 1,501,624 shares; 2025Q2: 1,501,624 shares; 2025Q3: 1,676,624 shares; 2025Q4: 1,676,624 shares; 2026Q1: 1,676,624 shares; 2026Q2: 1,676,624 shares; 2026Q3: 1,676,624 shares 1,676,624$148M4.17%0Timeline
KRSAKORSANA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 4,549,587 shares 4,549,587$146M4.11%newTimeline
KODKODIAK SCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,145,538 shares; 2025Q1: 1,145,538 shares; 2025Q2: 1,145,538 shares; 2025Q3: 1,145,538 shares; 2025Q4: 1,445,538 shares; 2026Q1: 1,445,538 shares; 2026Q2: 1,445,538 shares; 2026Q3: 1,445,538 shares 1,445,538$137M3.87%0Timeline
VORVOR BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 5,673,078 shares; 2026Q2: 5,673,078 shares; 2026Q3: 5,673,078 shares 5,673,078$108M3.06%0Timeline
TRAXFIRST TRACKS BIOTHERAPEUTICSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 2,895,304 shares; 2026Q3: 2,895,304 shares 2,895,304$103M2.9%0Timeline
MIRMMIRUM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 62,049 shares; 2026Q1: 1,062,049 shares; 2026Q2: 1,062,049 shares; 2026Q3: 1,118,967 shares 1,118,967$95.6M2.7%+56,918Timeline
BCRXBIOCRYST PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 11,020,968 shares; 2026Q2: 11,020,968 shares; 2026Q3: 11,020,968 shares 11,020,968$91.8M2.59%0Timeline
IRONDISC MEDICINE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 486,957 shares; 2025Q1: 465,257 shares; 2025Q2: 465,257 shares; 2025Q3: 465,257 shares; 2025Q4: not reported; 2026Q1: 1,341,862 shares; 2026Q2: 1,341,862 shares; 2026Q3: 1,341,862 shares 1,341,862$87.8M2.48%0Timeline
ADRXADARX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 4,116,452 shares 4,116,452$82.1M2.32%newTimeline
COGTCOGENT BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 6,964,375 shares; 2025Q1: 6,964,375 shares; 2025Q2: 6,964,375 shares; 2025Q3: 6,798,162 shares; 2025Q4: 5,868,162 shares; 2026Q1: 4,946,894 shares; 2026Q2: 4,854,436 shares; 2026Q3: 2,500,003 shares 2,500,003$80.1M2.26%-2,354,433Timeline
TYRATYRA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,989,103 shares; 2025Q1: 2,898,103 shares; 2025Q2: 2,898,103 shares; 2025Q3: 2,898,103 shares; 2025Q4: 2,898,103 shares; 2026Q1: 3,248,980 shares; 2026Q2: 3,248,980 shares; 2026Q3: 3,475,980 shares 3,475,980$76M2.15%+227,000Timeline
DYNDYNE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,650,150 shares; 2025Q1: 2,650,150 shares; 2025Q2: 3,766,660 shares; 2025Q3: 4,615,144 shares; 2025Q4: 4,615,144 shares; 2026Q1: 4,615,144 shares; 2026Q2: 4,615,144 shares; 2026Q3: 4,615,144 shares 4,615,144$74.3M2.1%0Timeline
RLAYRELAY THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 1,810,351 shares; 2025Q4: 3,220,186 shares; 2026Q1: 4,273,356 shares; 2026Q2: 4,273,356 shares; 2026Q3: 3,783,529 shares 3,783,529$68.3M1.93%-489,827Timeline
AURAAURA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 9,533,333 shares; 2026Q3: 10,165,357 shares 10,165,357$63.8M1.8%+632,024Timeline
SVRASAVARA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 12,362,205 shares; 2025Q1: 12,362,205 shares; 2025Q2: 12,362,205 shares; 2025Q3: 12,362,205 shares; 2025Q4: 12,362,205 shares; 2026Q1: 12,362,205 shares; 2026Q2: 12,362,205 shares; 2026Q3: 12,362,205 shares 12,362,205$63.8M1.8%0Timeline
XNCRXENCOR INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,452,138 shares; 2025Q1: 2,452,138 shares; 2025Q2: 2,452,138 shares; 2025Q3: 2,452,138 shares; 2025Q4: 2,452,138 shares; 2026Q1: 2,452,138 shares; 2026Q2: 2,452,138 shares; 2026Q3: 2,055,938 shares 2,055,938$51.3M1.45%-396,200Timeline
AVTXAVALO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 483,000 shares; 2025Q1: 483,000 shares; 2025Q2: 483,000 shares; 2025Q3: 483,000 shares; 2025Q4: 483,000 shares; 2026Q1: 738,383 shares; 2026Q2: 3,017,120 shares; 2026Q3: 3,017,120 shares 3,017,120$46.3M1.31%0Timeline
GLUEMONTE ROSA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 4,622,151 shares; 2026Q1: 4,622,151 shares; 2026Q2: 4,622,151 shares; 2026Q3: 3,781,532 shares 3,781,532$45.1M1.27%-840,619Timeline
MBXMBX BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 650,000 shares; 2025Q1: 650,000 shares; 2025Q2: 650,000 shares; 2025Q3: 650,000 shares; 2025Q4: 650,000 shares; 2026Q1: 650,000 shares; 2026Q2: 650,000 shares; 2026Q3: 650,000 shares 650,000$38.1M1.08%0Timeline
ENTXENTERA BIO LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 12,254,901 shares 12,254,901$35.7M1.01%newTimeline
JANXJANUX THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,789,617 shares; 2026Q1: 1,789,617 shares; 2026Q2: 1,789,617 shares; 2026Q3: 1,789,617 shares 1,789,617$30.9M0.87%0Timeline
TARSTARSUS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 388,164 shares 388,164$30.5M0.86%newTimeline
IPSCCENTURY THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 17,754,430 shares; 2026Q2: 17,754,430 shares; 2026Q3: 17,754,430 shares 17,754,430$30.4M0.86%0Timeline
OBXOBSIDIAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 2,196,138 shares 2,196,138$30.2M0.85%newTimeline
PHVSPHARVARIS N VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,008,229 shares; 2026Q3: 947,544 shares 947,544$30.1M0.85%-60,685Timeline
LBRXLB PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 1,745,016 shares; 2025Q4: 1,745,015 shares; 2026Q1: 1,839,489 shares; 2026Q2: 1,447,310 shares; 2026Q3: 765,050 shares 765,050$29.4M0.83%-682,260Timeline
EDITEDITAS MEDICINE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 11,111,111 shares; 2026Q3: 11,111,111 shares 11,111,111$28.6M0.81%0Timeline
TECXTECTONIC THERAPEUTIC INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,204,891 shares; 2026Q2: 1,204,891 shares; 2026Q3: 1,204,891 shares 1,204,891$28.1M0.79%0Timeline
IFRXINFLARX NVQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 14,500,000 shares; 2026Q3: 14,500,000 shares 14,500,000$26.1M0.74%0Timeline
CATXPERSPECTIVE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 7,915,567 shares; 2026Q2: 7,915,567 shares; 2026Q3: 7,915,567 shares 7,915,567$21.8M0.61%0Timeline
AGMBAGOMAB THERAPEUTICS NVQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 2,053,233 shares; 2026Q2: 2,053,233 shares; 2026Q3: 1,820,831 shares 1,820,831$20.2M0.57%-232,402Timeline
SLNSILENCE THERAPEUTICS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,033,560 shares; 2025Q1: 3,033,560 shares; 2025Q2: 3,033,560 shares; 2025Q3: 3,033,560 shares; 2025Q4: 3,033,560 shares; 2026Q1: 3,033,560 shares; 2026Q2: 3,033,560 shares; 2026Q3: 1,819,035 shares 1,819,035$19.9M0.56%-1,214,525Timeline
ALECALECTOR INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 10,000,000 shares; 2026Q1: 10,000,000 shares; 2026Q2: 10,000,000 shares; 2026Q3: 10,000,000 shares 10,000,000$18.5M0.52%0Timeline
BHVNBIOHAVEN LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 4,631,317 shares; 2026Q1: 4,631,317 shares; 2026Q2: 1,779,952 shares; 2026Q3: 1,262,423 shares 1,262,423$16.9M0.48%-517,529Timeline
MNPRMONOPAR THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 153,000 shares; 2025Q4: 141,915 shares; 2026Q1: 132,103 shares; 2026Q2: 203,327 shares; 2026Q3: 202,242 shares 202,242$16.1M0.46%-1,085Timeline
ADCTADC THERAPEUTICS SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 1,390,175 shares; 2025Q4: 11,390,175 shares; 2026Q1: 11,390,175 shares; 2026Q2: 11,390,175 shares; 2026Q3: 11,390,175 shares 11,390,175$13.9M0.39%0Timeline
TRDAENTRADA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 584,955 shares; 2025Q1: 584,955 shares; 2025Q2: 584,955 shares; 2025Q3: 584,955 shares; 2025Q4: 2,088,392 shares; 2026Q1: 2,287,500 shares; 2026Q2: 1,060,230 shares; 2026Q3: 1,060,230 shares 1,060,230$6.73M0.19%0Timeline
CGEMCULLINAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 406,786 shares; 2026Q2: 406,786 shares; 2026Q3: 406,786 shares 406,786$6.24M0.18%0Timeline
AGENAGENUS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 603,892 shares 603,892$6M0.17%newTimeline
OCULOCULAR THERAPEUTIX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 5,319,148 shares; 2025Q1: 5,319,148 shares; 2025Q2: 5,319,148 shares; 2025Q3: 6,117,232 shares; 2025Q4: 5,740,231 shares; 2026Q1: 1,647,752 shares; 2026Q2: 1,647,752 shares; 2026Q3: 720,323 shares 720,323$5.52M0.16%-927,429Timeline
ARVNARVINAS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 1,617,365 shares; 2025Q4: 2,666,216 shares; 2026Q1: 2,387,461 shares; 2026Q2: 707,098 shares; 2026Q3: 707,098 shares 707,098$5.47M0.15%0Timeline
KRROKORRO BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 416,301 shares; 2025Q4: 416,301 shares; 2026Q1: 416,301 shares; 2026Q2: 416,301 shares; 2026Q3: 416,301 shares 416,301$4.13M0.12%0Timeline
RACDRESEARCH ALLIANCE CORP IVQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 300,000 shares 300,000$3.6M0.1%newTimeline
ALXOALX ONCOLOGY HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 13,011,849 shares; 2026Q2: 5,655,487 shares; 2026Q3: 2,465,436 shares 2,465,436$3.43M0.1%-3,190,051Timeline
AKTSAKTIS ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 696,560 shares; 2026Q3: 133,457 shares 133,457$2.6M0.07%-563,103Timeline
JATTJATT II ACQUISITION CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 200,000 shares; 2026Q3: 200,000 shares 200,000$2.25M0.06%0Timeline
LONALEONABIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 464,398 shares; 2026Q1: 464,398 shares; 2026Q2: 464,398 shares; 2026Q3: 464,398 shares 464,398$1.66M0.05%0Timeline
JTTTJATT III ACQUISITION CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 100,000 shares 100,000$1.1M0.03%newTimeline
CNTXCONTEXT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 2,682,696 shares; 2026Q2: 2,682,696 shares; 2026Q3: 2,682,696 shares 2,682,696$806K0.02%0Timeline
EIKNEIKON THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 37,902 shares; 2026Q3: 37,902 shares 37,902$305K0.01%0Timeline

Sold out in Q3 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
RVMDREVOLUTION MEDICINES INC340,899$63.8Mshares
SRZNSURROZEN INC1,473,101$38.2Mshares
ALTALTIMMUNE INC10,000,000$30.4Mshares
FBRXFORTE BIOSCIENCES INC920,000$19.6Mshares
RACCRESEARCH ALLIANCE CORP III500,000$5.35Mshares

How Q3 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001214659-26-014306 base2026-11-16